7 Results for "

porcine plasma

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "porcine plasma" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-125864C
CAS No.: 9001-32-5
Research Areas:  

Cardiovascular Disease

Porcine Fibrinogen is a coagulation protein, purified from porcine plasma with no plasminogen contained. Porcine Fibrinogen has excellent biocompatibility and does not induce aggregation of porcine platelets when in contact with porcine hepatocytes, aortic endothelial cells or hepatic sinusoidal endothelial cells. Porcine Fibrinogen is widely used in studies on the pathological mechanisms of cardiovascular diseases such as atherosclerosis and the development of related drugs .
loading...
    loading...
Cat. No.: HY-P2795
CAS No.: 9001-01-8
Synonyms: kininogenase; SK-827
Target:  

Endogenous Metabolite

Research Areas:  

Others

Kallikrein, Porcine pancreas (kininogenase) is capable of forming the kallikrenase kalinin system (KKS) in plasma and tissues, producing bradykinin and kalin peptides, respectively .
loading...
    loading...
Cat. No.: HY-P5640
CAS No.: 179264-81-4
Target:  

Bacterial Parasite

Research Areas:  

Infection

Tritrpticin is a porcine-derived antimicrobial peptide with properties such as membrane disruption and hemolysis. Tritrpticin disrupts the cell membranes of bacteria, fungi and Jurkat T cell leukemia cells and induces their death. Tritrpticin also enhances the efficacy of Metronidazole (HY-B0318) against *Trichomonas vaginalis*, reduces plasma endotoxin and inflammatory cytokine levels, restricts bacterial growth in blood and visceral tissues, decreases the mortality rate of septic shock in rats and enhances the therapeutic effect of ertapenem. Tritrpticin exhibits selective cytotoxicity against Jurkat T cell leukemia cells, while showing low toxicity to normal peripheral blood mononuclear cells and red blood cells, and can serve as a template for antimicrobial peptide design. Tritrpticin can be applied to research related to bacterial infections, fungal infections, trichomoniasis, septic shock and leukemia .
loading...
    loading...
Cat. No.: HY-135447
CAS No.: 284464-46-6
BM-531 is a dual-acting agent for thromboxane receptor (TXA2) antagonism and thromboxane synthase inhibition. BM-531 exerts anti-aggregatory effects on human citrated platelet-rich plasma (PRP), inhibiting Arachidonic acid (HY-109590A)-induced aggregation with an ED100 of 0.125 μM and U-46619 (HY-108566)-induced aggregation with an ED50 of 0.482 μM. BM-531 inhibits high-K +-induced contraction of porcine uterine smooth muscle .
loading...
    loading...
Cat. No.: HY-P2637
CAS No.: 94162-23-9
Target:  

Renin

Research Areas:  

Cardiovascular Disease

Renin inhibitory peptide, statine is an inhibitor of Renin. Renin inhibitory peptide, statine inhibits the plasma renin activity of human plasma renin, porcine renin, and sodium-depleted conscious dogs. Renin inhibitory peptide, statine reduces the mean arterial pressure of sodium-depleted conscious dogs, induces a sustained, dose-dependent decrease in blood pressure, and triggers a maximum hypotensive response. Renin inhibitory peptide, statine can be used in hypertension-related research .
loading...
    loading...
Cat. No.: HY-W563489
CAS No.: 88431-47-4
Synonyms: POCA
Clomoxir (POCA) is a carnitine palmitoyltransferase I (CPT I) inhibitor with hypoglycemic activity. Clomoxir mediates the inhibition of CPT I via its active form POCA-CoA. Clomoxir inhibits long-chain fatty acid oxidation, ketogenesis, gluconeogenesis, de novo synthesis of cholesterol and fatty acids, and also mildly inhibits acetyl-CoA carboxylase. Clomoxir reduces blood glucose levels in various rodent and porcine models, alters plasma NEFA and cholesterol concentrations, induces hepatic lipid accumulation, peroxisome proliferation and mild myocardial hypertrophy in rats, and stimulates the pentose phosphate pathway in cultured human fibroblasts. Clomoxir can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-W039750
CAS No.: 862274-39-3
Target:  

Amino Acid Oxidase

Research Areas:  

Neurological Disease

DAAO-IN-2 is a D-amino acid oxidase (DAAO) inhibitor, with an IC50 of 0.123 μM against human DAAO and a Kd value of 1 μM against porcine DAAO. DAAO-IN-2 can be used for the research of schizophrenia .
loading...
    loading...